Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension have?

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension has 36 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension published?

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension has 2017 year in the ScholarIQ index.

What is the open-access status of Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension?

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension has closed oa status in the ScholarIQ index.

What is the DOI of Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension?

The DOI for Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension is on the source record.

What is the PMID of Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension?

The PMID for Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension is on the source record.

What is the OpenAlex record for Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension?

The OpenAlex for Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension is on the source record.